Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
9
×
boston blog main
boston top stories
clinical trials
9
×
life sciences
national blog main
national top stories
san francisco blog main
fda
san francisco top stories
boston
cancer
cancer drugs
deals
investing
new york blog main
new york top stories
biotech ipos
third rock ventures
abbvie
alexion pharmaceuticals
alzheimer's disease
biogen
blackstone group
cancer immunotherapy
david goldstein
depression
eli lilly
epilepsy
essential tremor
europe blog main
european society for medical oncology
hepatitis b
ipo
kiran reddy
major depressive disorder
medicare
mirati therapeutics
national
nonalcoholic steatohepatitis
What
research
9
×
medicines
biotech
drug
ipo
cancer
new
companies
disease
drugs
gene
genetic
ipos
praxis
precision
proteins
revolution
stop
targets
way
week
abbvie
aims
alliance
alzheimer’s
annual
arrival
assessed
attention
backed
bio
biotechs
black
cancer’s
caught
cause
causing
central
ceo
clinic
Language
unset
Current search:
biotech
×
research
×
" clinical trials "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More